Dna modifying enzymes and active fragments and variants thereof and methods of use
US-2024301385-A1 · Sep 12, 2024 · US
Bacteriophage lytic enzymes as alternative antimicrobials
US8962297B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8962297-B2 |
| Application number | US-87413810-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 1, 2010 |
| Priority date | Sep 1, 2010 |
| Publication date | Feb 24, 2015 |
| Grant date | Feb 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to isolated Clostridium perfringens bacteriophage lytic enzymes from baccteriophages CP26F and CP39O, and uses in controlling Clostridium perfringens.
First claim
Opening claim text (preview).
What is claimed is: 1. An isolated Clostridium perfringens bacteriophage lytic enzyme, wherein the bacteriophage lytic enzyme is CP26F lysin and wherein, the isolated Clostridium perfringens bacteriophage lytic enzyme is expressed in an expression vector as a recombinant protein comprising an amino acid sequence that is at least about 90% identical to SEQ ID NO: 1 and a carboxy-terminal His-Tag, and wherein the bacteriophage lytic enzyme has activity that results in lysis of C…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
- C12N9/80Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8962297B2 cover?
- The present invention relates to isolated Clostridium perfringens bacteriophage lytic enzymes from baccteriophages CP26F and CP39O, and uses in controlling Clostridium perfringens.
- Who is the assignee on this patent?
- Seal Bruce S, Siragusa Gregory R, Simmons Ibn Mustafa A, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification C12N9/80. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).